Entreprise · 21/06/19991 min de lecture
Steris Laboratories, Inc.; Withdrawal of Approval of 55 Abbreviated New Drug Applications
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is withdrawing approval of 55 abbreviated new drug applications (ANDA's). Steris Laboratories, Inc., notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.